Evidence map›Paper›PMID 26414081›Full record

ReviewCurrent opinion in endocrinology, diabetes, and obesity2015

Bone loss in HIV: a contemporary review.

Corrilynn O Hileman, Allison Ross Eckard, Grace A McComsey

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in endocrinology, diabetes, and obesity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Biochemical Markers of Calcium and Bone Metabolism during and after Lactation in Ugandan Women with HIV on Universal Maternal Antiretroviral Therapy.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Corrilynn O HilemanaMetrohealth Medical Center bCase Western Reserve School of Medicine, Cleveland, Ohio cMedical University of South Carolina, Charleston, South Carolina dUniversity Hospitals Case Medical Center, Cleveland, Ohio, USA.
Allison Ross Eckard
Grace A McComsey
Case Western Reserve University · USMedical University of South Carolina · USUniversity Hospitals Case Medical Center · US

Funding

Vitamin D Status, Inflammation and Cardiac Risk in HIVK23HL116209 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI HILEMAN, CORRILYNN OLESKY · 2013 to 2017
$734k
Vitamin D status and HIV-related complications in children and young adultsK23HD069199 · NICHD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ECKARD, ALLISON ROSS · 2012 to 2016
$631k
NHLBI NIH HHS K23 HL116209NHLBI NIH HHS K23HL116209NICHD NIH HHS K23 HD069199NICHD NIH HHS K23HD069199
6 · The paper itself

Abstract

purpose of reviewBecause of antiretroviral therapy (ART), people are living with HIV infection longer than ever before. As this patient group ages, it is expected that medical comorbidities such as osteoporosis and fragility fractures will increase. The purpose of this review is to address the epidemiology and what is known regarding the pathogenesis of bone loss in people living with HIV infection with a focus on recently published literature. RECENT

findingsHIV-infected individuals are at increased risk for low bone mineral density and bone fractures. The cause of bone loss in HIV is multifactorial including traditional risk factors some of which disproportionately affect HIV-infected individuals and alterations in bone metabolism due to ART, HIV viral proteins and chronic inflammation. Lifestyle modification, changing ART, calcium and vitamin D supplementation and pharmacologic treatment for osteoporosis may all be employed to abrogate bone loss in this patient group. SUMMARY: Clinicians should be aware of the contributors to bone loss in people living with HIV in order to recognize high-risk individuals and to take appropriate steps to address modifiable risk factors to prevent future fracture.

Indexed as

Anti-HIV AgentsBone DensityHepatitis CHIV InfectionsHumansOsteoporosisRisk FactorsAnti-HIV Agents

Identifiers

PMID26414081
PMCPMC4663974
OpenAlexW2472208814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.